[ALNY] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
13-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -16.37%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 1,037,418 844,287 492,853 219,750 74,908 89,912 47,159 67.35%
PBT -1,126,993 -852,144 -855,600 -885,253 -760,674 -490,874 -410,108 18.34%
Tax 4,163 680 2,681 863 823 -25,603 -23,438 -
NP -1,131,156 -852,824 -858,281 -886,116 -761,497 -490,874 -410,108 18.41%
Tax Rate - - - - - - - -
Total Cost 2,168,574 1,697,111 1,351,134 1,105,866 836,405 580,786 457,267 29.60%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -109.04 -101.01 -174.15 -403.24 -1,016.58 -545.95 -869.63 -29.24%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -9.30 -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 11.68%
EPS Diluted -9.30 -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 11.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.